{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:16:28Z","timestamp":1747156588506,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.brachy.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T11:35:45Z","timestamp":1716896145000},"page":"463-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["I-125 eye-plaque seed economics: To re-use or to not re-use? A single institutional cost savings analysis of re-using I-125 radioactive seeds for eye\u2014Plaque brachytherapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-8519","authenticated-orcid":false,"given":"Louis","family":"Cappelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1481-145X","authenticated-orcid":false,"given":"Lydia","family":"Komarnicky-Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniy","family":"Vinogradskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-5334","authenticated-orcid":false,"given":"Firas","family":"Mourtada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.04.001_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.001_bib0002","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.04.001_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy,"},{"key":"10.1016\/j.brachy.2024.04.001_bib0004","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/jcb.2020.98108","article-title":"Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database","volume":"12","author":"Messer","year":"2020","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2024.04.001_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/OPTH.S235265","article-title":"Comparison of iodide-125 and ruthenium-106 brachytherapy in the treatment of choroidal melanomas","volume":"14","author":"Ghassemi","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.001_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0360-3016(93)90459-9","article-title":"Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy","volume":"27","author":"Finger","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.04.001_bib0007","series-title":"Principle and practice of radiation oncology","first-page":"864","article-title":"Tumors of the eye and orbit","author":"Halperin","year":"2019"},{"key":"10.1016\/j.brachy.2024.04.001_bib0008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5114\/jcb.2023.127837","article-title":"Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): stretching the therapeutic window in skin cancer","volume":"15","author":"Fionda","year":"2023","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2024.04.001_bib0009","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24","volume":"138","author":"Hawkins","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.001_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative Ocular Melanoma Study Group. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:20:16Z","timestamp":1732170016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1538472124000655"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.04.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"I-125 eye-plaque seed economics: To re-use or to not re-use? A single institutional cost savings analysis of re-using I-125 radioactive seeds for eye\u2014Plaque brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}